Colon Cancer
Showing NaN - NaN of 17
Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose
Recruiting
- Advanced Malignant Solid Neoplasm
- +5 more
- RSC-1255 Dose Escalation
- RSC-1255 Dose Expansion
-
Los Angeles, California
- +5 more
Oct 24, 2022
Oncology, Melanoma, Ovarian Cancer Trial in United States (E-602, Pembrolizumab)
Recruiting
- Oncology
- +16 more
- E-602
- Pembrolizumab
-
Grand Rapids, Michigan
- +4 more
May 27, 2022
Prevention of Colorectal Cancer Through Multiomics Blood Testing
Recruiting
- Colon Cancer
- +10 more
- Freenome test
-
Anniston, Alabama
- +173 more
Mar 9, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Colon Cancer Trial in United States (Panitumumab, Nivolumab, Ipilimumab)
Metastatic Colorectal Cancer, Colon Cancer, Rectal Cancer Trial in United States (IMMU-130)
Withdrawn
- Metastatic Colorectal Cancer
- +2 more
-
Santa Monica, California
- +6 more
Aug 12, 2021
Colon Cancer, Rectal Cancer Trial in Canada, United States (Ramucirumab, Icrucumab, mFOLFOX-6)
Completed
- Colon Cancer
- Rectal Cancer
- Ramucirumab
- +2 more
-
Cincinnati, Ohio
- +16 more
Jul 15, 2019
Cancer, Colon Cancer, Colorectal Cancer Trial in Worldwide (Pegfilgrastim, Placebo, Bevacizumab)
Study of Effects of L-Arginine in Colitis and Colon Cancer
Completed
- Ulcerative Colitis
- Colon Cancer
-
Nashville, TennesseeVanderbilt Hospital
Mar 30, 2017
Metastatic Colorectal Cancer, Colon Cancer, Colorectal Cancer Trial in United States (Placebo, AMG 655, Modified FOLFOX6)
Completed
- Metastatic Colorectal Cancer
- +3 more
- Placebo
- +3 more
-
Hot Springs, Arkansas
- +60 more
Mar 28, 2014
Colon Cancer Trial in United States (BLI850, polyethylene glycol 3350 based bowel preparation)
Completed
- Colon Cancer
- BLI850
- polyethylene glycol 3350 based bowel preparation
-
Anaheim, California
- +11 more
Dec 3, 2013